Table 1 M. abscessus susceptibilities (MIC, µg/ml) to antimicrobials

From: Use of epigenetically modified bacteriophage and dual beta-lactams to treat a Mycobacterium abscessus sternal wound infection

Strain

GD276

GD276-2

GD276-1

GD276p1

GD276p2

GD276p3

GD276p4

Morphotype

Mixeda

Smooth

Rough

Smooth

Rough

Smooth

Smooth

Source

Chest swab

Sternum

Sternum

Chest swab

Chest swab

Chest swab

Skin Biopsy

Amikacin

16 (S)b

16 (S)

16 (S)

16 (S)

16 (S)

16 (S)

32 (I)

Bedaquiline

0.06

ND

ND

0.12

0.12

0.12

0.12

Cefoxitin

64 (I)

32 (I)

128 (R)

128 (R)

32 (I)

32 (I)

32 (I)

Ciprofloxacin

>16 (R)

>4 (R)

4 (R)

>4 (R)

>4 (R)

>4 (R)

>4 (R)

Clarithromycin

16 (R)

16 (R)

>16 (R)

>16 (R)

>16 (R)

>16 (R)

>16 (R)

Clofazimine

0.25

0.25

0.25

0.25

0.12

0.25

0.5

Doxycycline

>8 (R)

>8 (R)

>8 (R)

>8 (R)

>8 (R)

>8 (R)

>8 (R)

Eravacycline

ND

ND

ND

0.12

ND

0.12

0.12

Imipenem

16 (I)

8 (I)

16 (I)

16 (I)

8 (I)

16 (I)

16 (I)

Linezolid

16 (I)

16 (I)

16 (I)

4 (S)

16 (I)

16 (I)

16 (I)

Moxifloxacin

>4 (R)

>4 (R)

>4 (R)

>4 (R)

>4 (R)

>4 (R)

>4 (R)

Omadacycline

ND

ND

ND

0.5

0.5

0.12

0.12

Tedizolid

ND

ND

ND

ND

ND

4

<0.6

Tigecycline

0.25

0.12

0.25

0.25

0.25

0.25

0.25

TMP-SMX

>4 (R)

4 (R)

>4 (R)

4 (R)

>4 (R)

>4 (R)

>4 (R)

  1. aSample contains both rough and smooth colony morphotype, which for phage testing were separated and designated GD276A and GD276B, with rough and smooth morphotypes, respectively.
  2. bMICs (µg/ml) are shown for each strain and antibiotic, with R, S, and I indicated resistant, sensitive, and intermediate phenotypes.